<DOC>
	<DOCNO>NCT01064791</DOCNO>
	<brief_summary>This study ass safety efficacy different dos sotrastaurin combine tacrolimus prevention acute rejection de novo renal transplantation .</brief_summary>
	<brief_title>Efficacy , Safety , Tolerability , Pharmacokinetics Sotrastaurin Combined With Tacrolimus vs. Mycophenolic Acid-tacrolimus Regimen Renal Transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Inclusion criterion : Recipients first second kidney transplant decease , live unrelated nonhuman leukocyte antigen ( HLA ) identical living relate donor . Recipients kidney cold ischemia time &lt; 30 hour . Recipients kidney donor 10 65 year old . Exclusion criterion : Multiorgan transplant recipient . Recipients organ nonheart beat donor . Patients receive second kidney allograft first allograft Functional less three year Patients treat drug strong inducer inhibitor cytochrome P450 3A4 ( CYP3A4 ) screen discontinue treatment . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Renal transplantation</keyword>
</DOC>